Excessive Muscular Fatigue in Patients with Spastic Paraparesis
Neurol 40:1271-1274, Miller,R.G.,et al, 1990
Demyelinating Diseases
In Rowlands Merritt's Textbk of Neurology, Lea & Febiger, Phila, 8th Ed, p. 749, Sibley,W.A.,et al, 1989
Prodromal Symptoms of Multiple Sclerosis in Primary Care
Ann Neurol 83:1162-1173, Disanto,G.,et al, 2018
Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014
Solitary Sclerosis
Neurol 78:540-544, Schmalstieg,W.F.,et al, 2012
Premenstrual Multiple Sclerosis Pseudoexacerbations: Role of Body Temperature and Prevention With Aspirin
Arch Neurol 63:1005-1008, Wingerchuk,D.M. &Rodriguez,M., 2006
Modafinil for Fatigue in MS
Neurol 64:1139-1143, Stankoff,B.,et al, 2005
Randomized Controlled Trial of Yoga and Exercise in Multiple Sclerosis
Neurol 62:2058-2064, Oken,B.S.,et al, 2004
Efficacy and Safety of Modafinil (Provigil) for the Treatment of Fatigue in Multiple Sclerosis: A Two Centre Phase 2 Study
JNNP 72:179-183,150, Rammohan,K.W.,et al, 2002
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Acute Motor Radiculopathy as a First Symptom of MS: Anatomic-radiologic Correlation
Neurol 56:1603-1604, Lavallee,P.,et al, 2001
Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999
Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999
An Open-Label Trial of Gabapentin Treatment of Paroxysmal Symptoms in Multiple Sclerosis Patients
Neurol 51:609-611, Solaro,C.,et al, 1998
Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Impact of Aerobic Training on Fitness and Quality of Life in Multiple Sclerosis
Ann Neurol 39:432-441, 4221996., Petajan,J.H.,et al, 1996
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995
Uhthoff's Symptom in Disorders of the Anterior Visual Pathways
Neurol 44:1036-1038, Lepore,F.E., 1994
A Double-Blind, Renadomized, Crossover Trial of Pemoline in Fatigue Assoc with Multiple Sclerosis
Neurol 42:1468-1471, Weinshenker,B.G.,et al, 1992
"Fatigue"in Patients with Multiple Sclerosis
Arch Neurol 49:517-524, Sandroni,P.,et al, 1992
Multiple Sclerosis with Very Late Onset
Neurol 42:1907-1910, Hooge,J.P.&Redekop,W.K., 1992
Internal Capsule Plaque and Tonic Spasms in Multiple Sclerosis
Arch Neurol 48:427-429, Maimone,D.,et al, 1991
Uhthoff's Symptom in Optic Neuritis:Relationship to Magnetic Resonance Imaging & Development of Multiple Sclerosis
Ann Neurol 30:180-184, Scholl,G.B.,et al, 1991
The Sensitivity of Transcranial Cortical Magnetic Stimulation in Detecting Pyramidal Tract Lesions in Clin Definite MS
Neurol 41:566-569, Mayr,N.,et al, 1991
Multiple Sclerosis or HTLV-I Myelitis
Neurol 40:1020-1022, Poser,C.M.,et al, 1990
Clinicopath Conf
Acute Multiple Sclerosis, Case Record 42-1990, NEJM 323:1123-1135990., , 1990
Fulminant Monophasic Multiple Sclerosis, Marburg's Type
JNNP 53:918-921, Johnson,M.D.,et al, 1990
Amantadine Treatment of Fatigue Associated with Multiple Sclerosis
Arch Neurol 46:676-680, Cohen,R.A.&Fisher,M., 1989
Intrathecal Baclofen for Severe Spinal Spasticity
NEJM 320:1517-1521, 1553-15551989., Penn,R.D.,et al, 1989
Fatigue in Multiple Sclerosis
Arch Neurol 45:435-437, Krupp,L.B.,et al, 1988
Pain Syndromes in Multiple Sclerosis
Neurol 38:1830-1834, Moulin,D.E.,et al, 1988
Amantadine, Fatigue, and Multiple Sclerosis
Arch Neurol 45:1104-1106, Rosenberg,G.A.&Appenzeller,O., 1988
Antibody to Human T-Lymphotropic Virus Type I In West-Indian-Born UK Residents with Spastic Paraparesis
Lancet 1:415-416, Newton,M.,et al, 1987
Cranial Magnetic Resonance Imaging in the Evaluation of Myelopathy of Undetermined Etiology
Neurol 37:840-843, Miska,R.M.,et al, 1987
Retrovirus-Associated Myelopathies
Arch Neurol 44:659-663, Roman,G.C., 1987
Magnetic Resonance Imaging in Isolated Noncompressive Spinal Cord Syndromes
Ann Neurol 22:714-723, Miller,D.H.,et al, 1987
Paroxysmal Dystonia as the Initial Manifestation of Multiple Sclerosis
Arch Neurol 41:747-750, Berger,J.R.,et al, 1984
Multiple Sclerosis After Age 50
Neurol 33:1537-1544, Noseworthy,J.,et al, 1983
Clusters of Tonic Spasms as an Initial Manifestation of Multiple Sclerosis
Ann Neurol 12:494-495, Heath,P.D.,et al, 1982
Multiple Sclerosis:Early Prognostic Guidelines
Arch Phys Med Rehab 62:54-58, Kraft,G.H.,et al, 1981
Paroxysmal Symptoms as the First Manifestations of Multiple Sclerosis
JNNP 43:296-304, Twomey,J.A.,et al, 1980
Chronic Progressive Myelopathy:Investigation with CSF Electrophoresis, Evoked Potentials, & CT Scan
Ann Neurol 6:419-424, Patty,D.W.,et al, 1979
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975
Non-Invasive CNS Disease Associated with Lymphoid Tumors
CNS & LymphoidTumors, Johns Hopkins Med Jour 122:27168., Richter,R.,et al, 1968